Anaplastic Oligodendroglioma (AO) Terminated Phase 1 Trials for Ascorbic acid (DB00126)

Also known as: Anaplastic Oligodendroglioma / Anaplastic Oligodendrogliomas / Malignant oligodendroglioma / Oligodendroglioma, anaplastic (morphologic abnormality) / Oligodendroglioma malignant

IndicationStatusPhase
DBCOND0052374 (Anaplastic Oligodendroglioma (AO))Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02168270Temozolomide and Ascorbic Acid in Treating Patients With Recurrent High-Grade GliomaTreatment